End-of-day quote
Korea S.E.
06:00:00 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
27,100
KRW
|
+0.56%
|
|
+11.98%
|
+29.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
241,664
|
212,485
|
177,883
|
150,392
|
143,853
|
186,975
|
-
|
Enterprise Value (EV)
2 |
178.3
|
212.5
|
177.9
|
89.99
|
143.9
|
97.57
|
84.62
|
P/E ratio
|
-
|
-
|
7.87
x
|
8.45
x
|
6.29
x
|
7.41
x
|
6.64
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.35
x
|
3.68
x
|
-
|
1.68
x
|
1.52
x
|
1.72
x
|
1.51
x
|
EV / Revenue
|
2.47
x
|
3.68
x
|
-
|
1.01
x
|
1.52
x
|
0.9
x
|
0.68
x
|
EV / EBITDA
|
6.69
x
|
-
|
-
|
4.28
x
|
-
|
3.6
x
|
2.56
x
|
EV / FCF
|
7.8
x
|
-
|
-
|
5.24
x
|
-
|
5.08
x
|
3.7
x
|
FCF Yield
|
12.8%
|
-
|
-
|
19.1%
|
-
|
19.7%
|
27.1%
|
Price to Book
|
1.76
x
|
-
|
-
|
0.83
x
|
-
|
0.84
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
7,139
|
7,154
|
7,130
|
6,947
|
6,899
|
6,899
|
-
|
Reference price
3 |
33,850
|
29,700
|
24,950
|
21,650
|
20,850
|
27,100
|
27,100
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
72.13
|
57.77
|
-
|
89.4
|
94.63
|
108.6
|
123.6
|
EBITDA
1 |
26.64
|
-
|
-
|
21.02
|
-
|
27.1
|
33.1
|
EBIT
1 |
24.57
|
10.64
|
-
|
17.86
|
16.66
|
21.65
|
26.9
|
Operating Margin
|
34.06%
|
18.41%
|
-
|
19.98%
|
17.61%
|
19.93%
|
21.75%
|
Earnings before Tax (EBT)
1 |
28.92
|
9.356
|
-
|
19.46
|
-
|
32.2
|
34.5
|
Net income
1 |
25.94
|
-
|
22.65
|
17.87
|
23.3
|
25.35
|
28.7
|
Net margin
|
35.97%
|
-
|
-
|
19.99%
|
24.62%
|
23.33%
|
23.21%
|
EPS
2 |
-
|
-
|
3,172
|
2,563
|
3,316
|
3,656
|
4,079
|
Free Cash Flow
3 |
22,852
|
-
|
-
|
17,185
|
-
|
19,200
|
22,900
|
FCF margin
|
31,681.44%
|
-
|
-
|
19,222.93%
|
-
|
17,671.42%
|
18,520.02%
|
FCF Conversion (EBITDA)
|
85,786.78%
|
-
|
-
|
81,737.02%
|
-
|
70,848.71%
|
69,184.29%
|
FCF Conversion (Net income)
|
88,088.4%
|
-
|
-
|
96,177.57%
|
-
|
75,739.64%
|
79,790.94%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
20.5
|
25.9
|
27.9
|
32.8
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
2.2
|
3.9
|
6
|
10.8
|
Operating Margin
|
10.73%
|
15.06%
|
21.51%
|
32.93%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
1 |
6.4
|
6.1
|
5.9
|
10.8
|
Net margin
|
31.22%
|
23.55%
|
21.15%
|
32.93%
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
63.3
|
-
|
-
|
60.4
|
-
|
89.4
|
102
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
22,852
|
-
|
-
|
17,185
|
-
|
19,200
|
22,900
|
ROE (net income / shareholders' equity)
|
21.2%
|
6.56%
|
-
|
10.3%
|
12.1%
|
12%
|
11.9%
|
ROA (Net income/ Total Assets)
|
19.6%
|
-
|
-
|
9.67%
|
-
|
12.5%
|
11.8%
|
Assets
1 |
132.1
|
-
|
-
|
184.8
|
-
|
202.8
|
243.2
|
Book Value Per Share
3 |
19,190
|
-
|
-
|
26,171
|
-
|
32,436
|
36,751
|
Cash Flow per Share
|
3,769
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.61
|
-
|
-
|
1.68
|
-
|
1.5
|
1.5
|
Capex / Sales
|
0.85%
|
-
|
-
|
1.88%
|
-
|
1.38%
|
1.21%
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
27,100
KRW Average target price
40,000
KRW Spread / Average Target +47.60% Consensus |
1st Jan change
|
Capi.
|
---|
| +29.98% | 136M | | -26.40% | 1.51B | | +150.28% | 146M | | +21.41% | 82.58M |
Biometric Products
|